Have changes to the Scottish Medicines Consortium (SMC) process following the routledge review really improved access to Orphan Medications and what factors influence recommendations?
May 1, 2015, 00:00
10.1016/j.jval.2015.03.547
https://www.valueinhealthjournal.com/article/S1098-3015(15)00604-X/fulltext
Title :
Have changes to the Scottish Medicines Consortium (SMC) process following the routledge review really improved access to Orphan Medications and what factors influence recommendations?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00604-X&doi=10.1016/j.jval.2015.03.547
First page :
A93
Section Title :
Research Poster Presentations - Session II
Open access? :
No
Section Order :
1656